부산대학교 도서관

Purpose: The purpose of this study was to determine the effect of dapsone on platelet count in patients with human immunodeficiency virus (HIV)-related autoimmune thrombocytopenia.Patients and Methods: Eleven patients with HIV-related thrombocytopenia received dapsone (50 to 125 mg/day) for 2 to 43 months. Patients with the acquired immunodeficiency syndrome were not enrolled.Results: Of the 11 patients, six developed platelet counts above 50 X 10(9)/L and did not require any other specific therapy. No significant side effects were observed.Conclusion: We conclude that dapsone may be effective in some patients with HIV-related thrombocytopenia. [ABSTRACT FROM AUTHOR]